• ÆäÀ̽ººÏ °øÀ¯
  • Æ®À§ÅÍ °øÀ¯
  • ¹ÌÅõµ¥ÀÌ °øÀ¯
  • URLº¹»ç
  • ´õº¸±â
  • °ü½ÉÀÇ·áÁø µî·Ï

±è¸í±Ô

±è¸í±Ô

±è¸í±Ô ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
½ÅÀå³»°ú
¿ÀÈÄ
-
Á¾ÀÏ
¿ÀÀü
- - ½ÅÀåÀÌ½Ä , ¸¸¼º ½ÅÀå¿° , ±Þ¼º½ÅºÎÀü (¼ö(¿ÀÀü) ½ÅÀåÀ̽ÄŬ¸®´Ð:½ÅÀåÀÌ½Ä Áø·á)

±è¸í±Ô ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  •  ~  2000  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ÀÇÇаú Çлç
  •  ~  2004  :  °í·Á´ëÇб³ ´ëÇпø ÀÇÇаú ¼®»ç
  •  ~  2010  :  °í·Á´ëÇб³ ´ëÇпø ÀÇÇаú ¹Ú»ç

°æ·Â

more
  • 2008  ~  2010  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ÀüÀÓÀÇ
  • 2010  ~  2011  :  ¼­¿ï´ëÇб³ Àå±âÀ̽ļ¾ÅÍ ÀÓ»ó°­»ç
  • 2011  ~  2012  :  ¼­¿ï´ëÇб³ Àå±âÀ̽ļ¾ÅÍ Áø·áÁ¶±³¼ö
  • 2012  ~  2014  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø Á¶±³¼ö
  • 2015  ~  2017  :  ¹Ì±¹ NIH ±¹¸³º¸°Ç¿ø
  • 2014  ~  2020 .08  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ºÎ±³¼ö
  • 2020 .09  ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ±³¼ö

¼ö»ó³»¿ª

more
  • 2010  :  ´ëÇѽÅÀåÇÐȸ ¿ì¼öÃÊ·Ï
  • 2012  :  ´ëÇѽÅÀåÇÐȸ ¿ì¼öÃÊ·Ï
  • 2014  :  Á¦24ȸ °úÃÑ °úÇбâ¼ú¿ì¼ö³í¹®»ó
  • 2016  :  ´ëÇѽÅÀåÇÐȸ ÀþÀº¿¬±¸ÀÚ»ó
  • 2020  :  Á¦30ȸ °úÃÑ °úÇбâ¼ú¿ì¼ö³í¹®»ó

ÇÐȸȰµ¿

more
  •  ~   :  ´ëÇѳ»°úÇÐȸ È«º¸À§¿øÈ¸ À§¿ø
  •  ~   :  ´ëÇѽÅÀåÇÐȸ ÀϹÝÀÌ»ç
  •  ~   :  ´ëÇÑÀ̽ÄÇÐȸ °¨»ç, ÇмúÀ§¿øÈ¸ À§¿ø

³í¹®

more
  • [SCI] (M2 macrophages predict worse long-term outcomes in human acute tubular necrosis)
  • [±¹³»³í¹®] (In-depth review: Immunological Characteristics and Management of Kidney Transplantation)
  • [±¹³»³í¹®] (Cardiorenal syndrome (review))
  • [SCI] (Impact of aging on transition of acute kidney injury to chronic kidney disease)
  • [±¹¿Ü³í¹®] (The role of senescence of bone marrow cells in acute kidney injury)
  • [SCI] (Urine TIMP-2 and IGFBP7 as biomarkers of patients with established acute kidney injury)
  • [SCI] (Impact of donor age on the outcomes of kidney transplantation from deceased donors with histological acute kidney injury)
  • [SCI] (Combination of glomerular C4d and morphologic glomerular lesions as a possible indicator in the diagnosis of acute or chronic active antibody-mediated rejection)
  • [SCI] (The heat-shock protein-70-induced renoprotective effect is partially mediated by CD4+CD25+Foxp3+ regulatory T cells in ischemia/reperfusion-induced acute kidney injury)
  • [SCI] (IL-2/Anti-IL-2 Complex Attenuates Renal Ischemia-Reperfusion Injury through Expansion of Regulatory T Cells)
  • [SCI] (Outcomes of Combination Therapy for Chronic Antibody-Mediated Rejection in Renal Transplantation)
  • [SCI] (CD11c⁺ cells partially mediate the renoprotective effect induced by bone marrow-derived mesenchymal stem cells)
  • [SCI] (Clinical outcomes in kidney transplantation patients from deceased donors with acute kidney injury)
  • [SCI] (Postoperative hemolytic uremic syndrome with renal cortical necrosis following laparoscopic hemicolectomy)
  • [SCI] (Proinflammatory CD14+CD16+ monocytes are associated with vascular stiffness in predialysis patients with chronic kidney disease)
  • [±¹¿Ü³í¹®] (Management of Patients on the Waiting List for Deceased Donor Kidney Transplantation)
  • [±¹¿Ü³í¹®] (CD4+ CD25+ regulatory T cell partially mediate beneficial effect of FTY720, sphingosine-1-phosphate analog in ischemia/reperfusion induced acute kidney injury)
  • [±¹¿Ü³í¹®] (Depletion of kidney CD11c+ F4/80+ cells impairs the recovery process in ischaemia/reperfusion-induced acute kidney injury)
  • [±¹¿Ü³í¹®] (IL-10 mediates rosiglitazone-induced kidney protection in cisplatin nephrotoxicity)
  • [±¹³»³í¹®] Á¾¼³: ³ú»ç Àå±âÀÌ½Ä È°¼ºÈ­¸¦ À§ÇÑ ¿ì¸®³ª¶ó Àå±âÀÌ½Ä ¿î¿µ ¹× °ü¸®Ã¼Á¦

ÃÖÁ¾¼öÁ¤ÀÏ : 2020.11.06